Showing results (941-950 of 1,072) with videos related to
Sort By:
Pageof 108
Bone Marrow Transplantation|April 12, 2023
Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP/EBMTArnon Nagler, Myriam Labopin, Stephan Mielke, et al.Annals of Hematology|May 28, 2020
Comparison of central nervous system relapse outcomes following haploidentical vs identical-sibling transplant for acute lymphoblastic leukemiaQi Chen, Xin Zhao, Hai-Xia Fu, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 25, 2019
Incidence, Risk Factors, Outcomes, and Risk Score Model of Acute Pancreatitis after Allogeneic Hematopoietic Stem Cell TransplantationXing-Lin Wang, Wei Han, Peng Zhao, et al.British Journal of Haematology|May 26, 2025
Prognostic value of CEBPA bZIP signatures in cytogenetically normal acute myeloid leukaemiaLi-Xin Wu, Ming-Yue Liao, Ming-Yue Zhao, et al.Clinical Transplantation|November 22, 2020
The incidence, clinical outcome, and protective factors of mixed chimerism following hematopoietic stem cell transplantation for severe aplastic anemiaZheng-Li Xu, Yi-Fei Cheng, Yuan-Yuan Zhang, et al.Journal of Hematology & Oncology|March 20, 2019
Early myeloid-derived suppressor cells (HLA-DR-/lowCD33+CD16-) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease (GVHD) in humanized mouse and might contribute to lower GVHD in patients post allo-HSCTKe Wang, Meng Lv, Ying-Jun Chang, et al.Frontiers in Oncology|January 24, 2022
Preemptive Immunotherapy for Minimal Residual Disease in Patients With t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell TransplantationShuang Fan, Meng-Zhu Shen, Xiao-Hui Zhang, et al.Bone Marrow Transplantation|August 22, 2018
The significance of peri-transplantation minimal residual disease assessed by multiparameter flow cytometry on outcomes for adult AML patients receiving haploidentical allograftsJing Liu, Rui Ma, Yan-Rong Liu, et al.British Journal of Haematology|September 28, 2024
Mega-dose decitabine conditioning and prophylactic donor lymphocyte infusion for patients with relapsed/refractory AML with active disease at the time of allogeneic haematopoietic cell transplantation: A multicenter prospective phase II studyMeng Lv, Chen-Hua Yan, Rui Ma, et al.Thrombosis Research|June 5, 2016
High-dose corticosteroid associated with catheter-related thrombosis after allogeneic hematopoietic stem cell transplantationXiao-Hui Zhang, Fei-Er Feng, Wei Han, et al.Pageof 108